杂环类白藜芦醇衍生物的合成及其药理作用研究综述
Synthesis and Pharmacological Action of Heterocyclic Resveratrol Derivatives: A Review
DOI: 10.12677/JOCR.2022.102007, PDF,   
作者: 唐宗军, 刘海平, 马文晋:兰州交通大学化学化工学院,甘肃 兰州
关键词: 杂环白藜芦醇合成活性Heterocyclic Resveratrol Synthesis Activity
摘要: 白藜芦醇是众所周知的一种天然非黄酮类化合物,存在于多种植物中,并且具有丰富的药理作用。近年来,受到了广大研究人员广泛的研究。尤其是以白藜芦醇为基本骨架的衍生物,通过对其酚羟基,苯环,双键不同结构的修饰,进而研究其不同药理作用的变化。含有氮、氧、硫等杂原子的杂环具有特殊的药理性质,杂环化合物种类繁多,在自然界中分布广泛。因此,本文主要综述了恶唑、呋喃、噻吩、吡咯、咪唑等杂环对白藜芦醇不同位置修饰的衍生物的合成及药理作用的研究。
Abstract: Resveratrol is a well-known natural non flavonoid compound, which exists in a variety of plants and has rich pharmacological effects. In recent years, it has been widely studied by the majority of researchers. Especially for the derivatives with resveratrol as the basic skeleton, through the modification of different structures of phenolic hydroxyl, benzene ring and double bond, we can study the changes of their different pharmacological effects. Heterocycles containing heteroatoms such as nitrogen, oxygen and sulfur have special pharmacological properties. There are many kinds of heterocyclic compounds, which are widely distributed in nature. Therefore, this paper mainly reviews the synthesis and pharmacological effects of heterocycles such as oxazole, furan, thiophene, pyrrole and imidazole on resveratrol derivatives modified at different positions.
文章引用:唐宗军, 刘海平, 马文晋. 杂环类白藜芦醇衍生物的合成及其药理作用研究综述[J]. 有机化学研究, 2022, 10(2): 69-77. https://doi.org/10.12677/JOCR.2022.102007

参考文献

[1] Trela, B.C. and Waterhouse, A.L. (1996) Resveratrol: Isomeric Molar Absorptivities and Stability. Journal of Agricultural and Food Chemistry, 44, 1253-1257. [Google Scholar] [CrossRef
[2] Baur, J.A. and Sinclair, D.A. (2006) Therapeutic Potential of Resveratrol: The in Vivo Evidence. Nature Reviews Drug Discovery, 5, 493-506. [Google Scholar] [CrossRef] [PubMed]
[3] Aggarwal, B.B. and Shishodia, S. (2005) Resveratrol in Health and Disease. CRC Press, Boca Raton. [Google Scholar] [CrossRef
[4] Schneider, Y., Vincent, F., Duranton, B., et al. (2000) Anti-Proliferative Effect of Resveratrol, a Natural Component of Grapes and Wine, on Human Colonic Cancer Cells. Cancer Letters, 158, 85-91. [Google Scholar] [CrossRef
[5] Uenobe, F., Nakamura, S.I. and Miyazawa, M. (1997) Antimutagenic Effect of Resveratrol against Trp-P-1. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 373, 197-200. [Google Scholar] [CrossRef
[6] Rizzoli, R., Bruyere, O., Cannata-Andia, J.B., et al. (2009) Management of Osteoporosis in the Elderly. Current Medical Research & Opinion, 25, 2373-2387. [Google Scholar] [CrossRef] [PubMed]
[7] Shigekazu, T., Yukiko, M., Norifumi, K., et al. (1998) Extracellular Nucleotides Modulate the Portal Circulation with Generation of Nitric Oxide. Hepatology Research, 27, 1265-1274.
[8] Docherty, J.J., Fu, M.M.H., Stiffler, B.S., et al. (1999) Resveratrol Inhibition of Herpes Simplex Virus Replication. Antiviral Research, 43, 145-155. [Google Scholar] [CrossRef
[9] Gehm, B.D., McAndrews, J.M., Chien, P.Y., et al. (1997) Resveratrol, a Polyphenolic Compound Found in Grapes and Wine, Is an Agonist for the Estrogen. Proceedings of the National Academy of Sciences of the United States of America, 94, 14138-14143. [Google Scholar] [CrossRef] [PubMed]
[10] Virgili, M. and Contestabile, A. (2000) Partial Neuroprotection of in Vivo Excitotoxic Brain Damage by Chronic Administration of the Red Wine Antioxidant Agent, Trans-Resveratrol in Rats. Neuroscience Letters, 281, 123-126. [Google Scholar] [CrossRef
[11] Kopp, P. (1998) Resveratrol, a Phytoestrogen Found in Red Wine. A Possible Explanation for the Conundrum of the ‘French Paradox’? European Journal of Endocrinology, 138, 619-620. [Google Scholar] [CrossRef] [PubMed]
[12] Devi, E.R., Sreenivasulu, R., Rao, K.P., et al. (2019) Novel 1,3,4-Thiadiazole Linked Amide Derivatives of Pteridone: Synthesis and Study of Anticancer Activities. Letters in Organic Chemistry, 17, 54-60. [Google Scholar] [CrossRef
[13] Spandana, Z., Sreenivasulu, R., Rekha, T.M., et al. (2019) Novel 1,3,4-Oxadiazole Fused Thiadiazole Derivatives: Synthesis and Study of Anticancer Activities. Letters in Drug Design & Discovery, 16, 656-662. [Google Scholar] [CrossRef
[14] Kanth, B.S., Kumar, A.S., Shinde, D.B., et al. (2011) New Bioactive Macrocyclic Diterpenoids from Jatropha multifida. Bioorganic & Medicinal Chemistry Letters, 21, 6808-6810. [Google Scholar] [CrossRef] [PubMed]
[15] Sreenivasulu, R., Tej, M.B., Jadav, S.S., et al. (2020) Synthesis, Anticancer Evaluation and Molecular Docking Studies of 2,5-Bis(Indolyl)-1,3,4-Oxadiazoles, Nortopsentin Analogues. Journal of Molecular Structure, 1208, Article ID: 127875. [Google Scholar] [CrossRef
[16] He, S. and Yan, X.J. (2013) From Resveratrol to Its Derivatives: New Sources of Natural Antioxidant. Current Medicinal Chemistry, 20, 1005-1017. [Google Scholar] [CrossRef] [PubMed]
[17] Quezada, E., Delogu, G., Picciau, C., et al. (2010) Synthesis and Vasorelaxant and Platelet Antiaggregatory Activities of a New Series of 6-Halo-3-Phenylcoumarins. Molecules, 15, 270-279. [Google Scholar] [CrossRef] [PubMed]
[18] Azzolini, M., Mattarei, A., Spina, M.L., et al. (2015) Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol. Molecular Pharmaceutics, 12, 3441-3454. [Google Scholar] [CrossRef] [PubMed]
[19] Vema, V.N., Kumari, B., Mandava, V.B.R., et al. (2020) Synthesis, Anticancer Evaluation and Molecular Docking Studies of 1,3,4-Oxadiazole Linked Resveratrol Derivatives. Chemical Data Collections, 30, Article ID: 100570. [Google Scholar] [CrossRef
[20] Gobec, M., Tomašic, T., Markovic, T., et al. (2015) Antioxidant and Anti-Inflammatory Properties of 1,2,4-Oxadiazole Analogs of Resveratrol. Chemico-Biological Interactions, 240, 200-207. [Google Scholar] [CrossRef] [PubMed]
[21] Jin, L., Ren, Y.J. and Du, C. (2015) Synthesis and Antitumor Activities of Resveratrol Derivatives on Cervical Cancer Hela Cells. Chemistry of Natural Compounds, 51, 652-655. [Google Scholar] [CrossRef
[22] Yang, H.J., Ren, Y.J., Du, C., et al. (2018) Synthesis and Anticoagulant Bioactivity of Heterocyclic Derivatives of Resveratrol. Chemistry of Natural Compounds, 54, 864-868. [Google Scholar] [CrossRef
[23] Siddiqui, A., Dandawate, P., Rub, R., et al. (2013) Novel Aza-Resveratrol Analogs: Synthesis, Characterization and Anticancer Activity against Breast Cancer Cell Lines. Bioorganic & Medicinal Chemistry Letters, 23, 635-640. [Google Scholar] [CrossRef] [PubMed]
[24] Bellina, F., Guazzelli, N., Lessi, M., et al. (2015) Imidazole Analogues of Resveratrol: Synthesis and Cancer Cell Growth Evaluation. Tetrahedron, 71, 2298-2305. [Google Scholar] [CrossRef
[25] Meng, X.L., Yang, J.Y., Chen, J.L., et al. (2008) Effects of Resveratrol and Its Derivatives on Lipopolysaccharide-Induced Microglial Activation and Their Structure-Activity Relationships. Chemico-Biological Interactions, 174, 51-59. [Google Scholar] [CrossRef] [PubMed]
[26] Pawlikowska-Pawlega, B., Kapral, J., Gawron, A., et al. (2018) Interaction of a Quercetin Derivative-Lensoside Aβ with Liposomal Membranes. Biochimica et Biophysica Acta, 1860, 292-299. [Google Scholar] [CrossRef] [PubMed]
[27] Majumdar, P., Pati, A., Patra, M., et al. (2014) ChemInform Abstract: Acid Hydrazides, Potent Reagents for Synthesis of Oxygen-, Nitrogen-, and/or Sulfur-Containing Heterocyclic Rings. ChemInform, 45, 2942-2977. [Google Scholar] [CrossRef
[28] Eftekhari-Sis, B., Zirak, M. and Akbari, A. (2013) Arylglyoxals in Synthesis of Heterocyclic Compounds. Chemical Reviews, 113, 2958-3043. [Google Scholar] [CrossRef] [PubMed]
[29] Zhang, X.J., Zhu, J., Xiong, X.Y., et al. (2004) Synthesis of Resveratrol and Resveratrol Trinicotinate. Journal of Chinese Pharmaceutical Sciences, 13, 10-13.
[30] Fan, H.T., Xiong, X.Y., Cao, W., et al. (2006) Effect of Resveratrol Trinicotinate versus Resveratrol against Tumors in Vitro and in Vivo. Chinese Journal of New Drugs, 15, 874-878.
[31] Liu, H.C., Dong, A.J., Gao, C., et al. (2008) The Design, Synthesis, and Anti-Tumor Mechanism Study of N-Phosphoryl Amino Acid Modified Resveratrol Analogues. Bioorganic & Medicinal Chemistry, 16, 10013-10021. [Google Scholar] [CrossRef] [PubMed]